In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...
ISCHAEMIC heart diseases remained the leading cause of death in the Philippines from January to June 2025, followed by ...
A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, FLORIDA / ACCESS Newswire / January 7, 2026 / The Assistance Fund, an inde ...
Histological analysis of the resected specimen diagnosed a Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) with mild lymphocytic submucosal inflammation. Crucially, there was no ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...
We’ve seen the first AI-generated commercials, songs and even social media influencers outside of healthcare. Will pharma be ...
Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker ...
A difficult year comes to a close, leaving me with a tough challenge.” Igor Protti published a post on Instagram to bid ...
Janus Kinase inhibitors (JAKis) are approved for the management of several chronic inflammatory diseases, from rheumatic conditions, to dermatological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback